News & Analysis on Clinical Trial Services & Contract Research And Development
Inovio Biomedical, a US company developing novel DNA immunotherapies and other treatments based on electroporation technology, has reported interim data from a Phase I/II clinical study showing that its MedPulser system significantly enhanced the...
The end of premature ejaculation is in sight as a simple inhalation of a drug promises to prolong the action under the sheets.
YM BioSciences today announced that the upgraded manufacturing facility for the firm's humanized monoclonal antibody (MAb) for the treatment of cancer has successfully passed a series of regulatory reviews.
UK biotech firm Acambis has decided to bring the manufacturing of its soon to be approved smallpox vaccine in-house while its agreement with contract manufacturer Baxter comes to an end.
Albany Molecular Research (AMRI) has followed up its push into new markets for its drug discovery operations by tapping into the well-established trend for sourcing contract pharmaceutical manufacturing from the lower-cost Asian region.
Indian firm Alembic has landed a licensing deal with biopharma heavyweight UCB to apply the company's novel drug delivery system for a once-a-day version of UCB's market leading epilepsy drug.
MFIC is looking to introduce a new microfluidic system that could help pharmaceutical and biotechnology companies to manufacture difficult to formulate drugs.
The latest Advances in Microarray Technology (AMT) conference, held in conjunction with the Lab-on-a-Chip World Congress highlighted the movement of the fields from the research lab into diagnostics.